PET/CT Interpretative Pitfalls in Thoracic Malignancies

Girish S. Shroff; Bradley S. Sabloff; Mylene T. Truong; Brett W. Carter; Chitra Viswanathan

doi:10.1053/j.sult.2018.02.007

PET/CT Interpretative Pitfalls in Thoracic Malignancies

Girish S. Shroff, Bradley S. Sabloff, Mylene T. Truong, Brett W. Carter, Chitra Viswanathan

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Applications of positron emission tomography/computed tomography (PET/CT) in the thorax include the evaluation of solitary pulmonary nodules, staging and restaging of oncologic patients, assessment of therapeutic response, and detection of residual or recurrent disease. Accurate interpretation of PET/CT requires knowledge of the physiological distribution of [18 F]-fluoro-2-deoxy-D-glucose, as well as artifacts and quantitative errors due to the use of CT for attenuation correction of the PET scan. Potential pitfalls include malignancies that are PET negative and benign conditions that are PET positive. Awareness of these artifacts and potential pitfalls is important in preventing misinterpretation that can alter patient management.

Original language	English (US)
Pages (from-to)	282-288
Number of pages	7
Journal	Seminars in Ultrasound, CT and MRI
Volume	39
Issue number	3
DOIs	https://doi.org/10.1053/j.sult.2018.02.007
State	Published - Jun 2018

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1053/j.sult.2018.02.007

Cite this

@article{0571917ae99a4a0bb9df2bf1acc93177,

title = "PET/CT Interpretative Pitfalls in Thoracic Malignancies",

abstract = "Applications of positron emission tomography/computed tomography (PET/CT) in the thorax include the evaluation of solitary pulmonary nodules, staging and restaging of oncologic patients, assessment of therapeutic response, and detection of residual or recurrent disease. Accurate interpretation of PET/CT requires knowledge of the physiological distribution of [18 F]-fluoro-2-deoxy-D-glucose, as well as artifacts and quantitative errors due to the use of CT for attenuation correction of the PET scan. Potential pitfalls include malignancies that are PET negative and benign conditions that are PET positive. Awareness of these artifacts and potential pitfalls is important in preventing misinterpretation that can alter patient management.",

author = "Shroff, {Girish S.} and Sabloff, {Bradley S.} and Truong, {Mylene T.} and Carter, {Brett W.} and Chitra Viswanathan",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = jun,

doi = "10.1053/j.sult.2018.02.007",

language = "English (US)",

volume = "39",

pages = "282--288",

journal = "Seminars in Ultrasound, CT and MRI",

issn = "0887-2171",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - PET/CT Interpretative Pitfalls in Thoracic Malignancies

AU - Shroff, Girish S.

AU - Sabloff, Bradley S.

AU - Truong, Mylene T.

AU - Carter, Brett W.

AU - Viswanathan, Chitra

PY - 2018/6

Y1 - 2018/6

N2 - Applications of positron emission tomography/computed tomography (PET/CT) in the thorax include the evaluation of solitary pulmonary nodules, staging and restaging of oncologic patients, assessment of therapeutic response, and detection of residual or recurrent disease. Accurate interpretation of PET/CT requires knowledge of the physiological distribution of [18 F]-fluoro-2-deoxy-D-glucose, as well as artifacts and quantitative errors due to the use of CT for attenuation correction of the PET scan. Potential pitfalls include malignancies that are PET negative and benign conditions that are PET positive. Awareness of these artifacts and potential pitfalls is important in preventing misinterpretation that can alter patient management.

AB - Applications of positron emission tomography/computed tomography (PET/CT) in the thorax include the evaluation of solitary pulmonary nodules, staging and restaging of oncologic patients, assessment of therapeutic response, and detection of residual or recurrent disease. Accurate interpretation of PET/CT requires knowledge of the physiological distribution of [18 F]-fluoro-2-deoxy-D-glucose, as well as artifacts and quantitative errors due to the use of CT for attenuation correction of the PET scan. Potential pitfalls include malignancies that are PET negative and benign conditions that are PET positive. Awareness of these artifacts and potential pitfalls is important in preventing misinterpretation that can alter patient management.

UR - http://www.scopus.com/inward/record.url?scp=85044533507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044533507&partnerID=8YFLogxK

U2 - 10.1053/j.sult.2018.02.007

DO - 10.1053/j.sult.2018.02.007

M3 - Article

C2 - 29807638

AN - SCOPUS:85044533507

SN - 0887-2171

VL - 39

SP - 282

EP - 288

JO - Seminars in Ultrasound, CT and MRI

JF - Seminars in Ultrasound, CT and MRI

IS - 3

ER -

PET/CT Interpretative Pitfalls in Thoracic Malignancies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this